Fig. 3: Delivery barriers and administration routes for lipid nanoparticle–mRNA formulations. | Nature Reviews Materials

Fig. 3: Delivery barriers and administration routes for lipid nanoparticle–mRNA formulations.

From: Lipid nanoparticles for mRNA delivery

Fig. 3

a | Physiological barriers for lipid nanoparticle–mRNA (LNP–mRNA) formulations post systemic and local delivery. b | Administration routes for LNP–mRNA formulations. Panel b reprinted from ref.155, Springer Nature Limited.

Back to article page